Redsense Medical AB (REDS) — Cash Flow Reinvestment Rate
Latest as of March 2025:
0.14x
Redsense Medical AB (REDS) has a Cash Flow Reinvestment Rate of 0.14x as of March 2025, reinvesting Skr105.00K (capex Skr105.00K ) from operating cash flow of Skr761.00K. See REDS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.14x
(Capex + Investments) / Operating CF
Total Reinvested
Skr105.00K
Capex + Investments
Operating Cash Flow
Skr761.00K
SEK
Capital Expenditures
Skr105.00K
SEK
Redsense Medical AB Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Redsense Medical AB across 1 annual periods. For the full cash flow conversion analysis, see REDS cash flow conversion.
Annual Cash Flow Reinvestment Rate for Redsense Medical AB (2020–2020)
Year-by-year capital reinvestment analysis for Redsense Medical AB. See Redsense Medical AB (REDS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 5.90x | Skr101.62 Million | Skr17.23 Million | Skr37.08 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow